A Mounjaro price cut in Brazil, days before a cheaper local pen arrives, has touched off a price war in the country's fast-growing weight-loss drug market.
Brazil · Corporates
Key Facts
—The cut. Eli Lilly trimmed the price of its weight-loss drug Mounjaro in Brazil by as much as 36 percent through a loyalty program.
—The numbers. A starter pack fell from about R$3,350 ($666) to R$2,250 ($447), with some combinations down by more than R$2,000.
—The trigger. The cut landed days before EMS, a Brazilian drugmaker, launched a cheaper local pen called Ozivy.
Sales of weight-loss drugs in Brazil are reshaping pharmacy chains, now near a tenth of revenue, as a cheaper home-made version…
The recommended UK price will rise by up to 170%, although the impact on consumers could be more limited.
The rebate allays fears of a 170% price rise but patients are warned the cost of the drug will still jump.
At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions
BRAZIL · ECONOMY Key Facts —The approval: Brazil's health regulator cleared Ozivy, the country's first home-grown version of…
At least 500,000 people in the UK take either Mounjaro or Wegovy, another weight-loss jab, through private prescriptions
